This is a great resource for both providers and patients navigating treatment with these powerful agents.
The findings come at a moment when scientists are exploring the use of GLP-1 drugs to treat other conditions beyond type 2 diabetes and obesity, such as sleep apnea and addiction
Table of Contents How GLP-1 Medications Affect Taste and Food Preferences Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes management and weight loss
Lip fillers provide longer-lasting results than the lip flip
Tirzepatide works through a fundamentally different mechanism, targeting two receptors instead of one, and the clinical data shows it consistently outperforms semaglutide for both weight loss and metabolic improvement
A Smarter Way to Approach Weight Loss Decisions Selecting the most appropriate weight loss solution requires one to consider more than the popular weight loss methods